PT859630E - Combinacao de temozolomida e alfa-ifn no tratamento de cancro avancado - Google Patents
Combinacao de temozolomida e alfa-ifn no tratamento de cancro avancadoInfo
- Publication number
- PT859630E PT859630E PT96935971T PT96935971T PT859630E PT 859630 E PT859630 E PT 859630E PT 96935971 T PT96935971 T PT 96935971T PT 96935971 T PT96935971 T PT 96935971T PT 859630 E PT859630 E PT 859630E
- Authority
- PT
- Portugal
- Prior art keywords
- temozolomide
- combination
- alpha
- ifn
- advanced cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US623395P | 1995-10-04 | 1995-10-04 | |
| US62541096A | 1996-03-27 | 1996-03-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT859630E true PT859630E (pt) | 2003-02-28 |
Family
ID=26675350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT96935971T PT859630E (pt) | 1995-10-04 | 1996-10-01 | Combinacao de temozolomida e alfa-ifn no tratamento de cancro avancado |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0859630B1 (pt) |
| JP (2) | JP4156028B2 (pt) |
| AT (1) | ATE229343T1 (pt) |
| AU (1) | AU719074B2 (pt) |
| CA (1) | CA2233544A1 (pt) |
| DE (1) | DE69625373T2 (pt) |
| DK (1) | DK0859630T3 (pt) |
| ES (1) | ES2183977T3 (pt) |
| PT (1) | PT859630E (pt) |
| WO (1) | WO1997012630A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE310515T1 (de) * | 1999-03-30 | 2005-12-15 | Schering Corp | Verbesserte krebsbehandlung mit temozolomid |
| EP1908477A3 (en) * | 2000-01-24 | 2008-06-11 | Schering Corporation | Combination of temozolomide and pegylated interferon-alpha for treating cancer |
| AU2001232951A1 (en) * | 2000-01-24 | 2001-07-31 | Schering Corporation | Combination of temozolomide and pegylated interferon-alpha for treating cancer |
| EP1909822B1 (en) | 2005-06-29 | 2013-09-25 | Yeda Research And Development Co., Ltd. | Recombinant interferon alpha 2 (ifn alpha 2) mutants |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5017371A (en) * | 1988-01-06 | 1991-05-21 | Amarillo Cell Culture Company, Incorporated | Method for reducing side effects of cancer therapy |
| AU634511B2 (en) * | 1988-12-01 | 1993-02-25 | Schering Corporation | Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon |
| AU651998B2 (en) * | 1990-10-12 | 1994-08-11 | F. Hoffmann-La Roche Ag | Use of a retinoid |
| DE4244548C2 (de) * | 1992-12-30 | 1997-10-02 | Stockhausen Chem Fab Gmbh | Pulverförmige, unter Belastung wäßrige Flüssigkeiten sowie Blut absorbierende Polymere, Verfahren zu ihrer Herstellung und ihre Verwendung in textilen Konstruktionen für die Körperhygiene |
-
1996
- 1996-10-01 WO PCT/US1996/015413 patent/WO1997012630A1/en active IP Right Grant
- 1996-10-01 AU AU73731/96A patent/AU719074B2/en not_active Ceased
- 1996-10-01 JP JP51432197A patent/JP4156028B2/ja not_active Expired - Fee Related
- 1996-10-01 PT PT96935971T patent/PT859630E/pt unknown
- 1996-10-01 CA CA002233544A patent/CA2233544A1/en not_active Abandoned
- 1996-10-01 ES ES96935971T patent/ES2183977T3/es not_active Expired - Lifetime
- 1996-10-01 AT AT96935971T patent/ATE229343T1/de active
- 1996-10-01 EP EP96935971A patent/EP0859630B1/en not_active Expired - Lifetime
- 1996-10-01 DE DE69625373T patent/DE69625373T2/de not_active Expired - Lifetime
- 1996-10-01 DK DK96935971T patent/DK0859630T3/da active
-
2007
- 2007-03-26 JP JP2007080381A patent/JP2007169300A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| ES2183977T3 (es) | 2003-04-01 |
| AU7373196A (en) | 1997-04-28 |
| CA2233544A1 (en) | 1997-04-10 |
| WO1997012630A1 (en) | 1997-04-10 |
| EP0859630B1 (en) | 2002-12-11 |
| ATE229343T1 (de) | 2002-12-15 |
| JP2007169300A (ja) | 2007-07-05 |
| JPH11514995A (ja) | 1999-12-21 |
| DE69625373D1 (de) | 2003-01-23 |
| DK0859630T3 (da) | 2003-03-24 |
| JP4156028B2 (ja) | 2008-09-24 |
| AU719074B2 (en) | 2000-05-04 |
| EP0859630A1 (en) | 1998-08-26 |
| DE69625373T2 (de) | 2003-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT880350E (pt) | Tratamento de esclerose multipla | |
| MY113059A (en) | Controlled-release dosage forms of azithromycin | |
| NZ309217A (en) | Ribavirin and interferon alpha for the treatment of hepatitis C | |
| NO932610L (no) | Fremgangsmaate for behandling av tumornekrosefaktor formidlede sykdommer | |
| GEP20002146B (en) | Therapeutic Peptide Derivatives | |
| HU883981D0 (en) | Process for the production of medical preparations with antiviral or antibacterial effect | |
| FI971290A (fi) | Multippeliskleroosin (MS) ja muiden myeliinikadosta aiheutuvien sairauksien hoito | |
| ATE258796T1 (de) | Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen | |
| GEP20032910B (en) | Method for Prophylaxis of Breast Cancer | |
| DE69734450D1 (de) | Photopherese-behandlung von hcv-infektionen | |
| DE69512760D1 (de) | Verwendung von Melatonin zur Behandlung von Patienten die an Drogenabhängigkeit leiden | |
| PT859630E (pt) | Combinacao de temozolomida e alfa-ifn no tratamento de cancro avancado | |
| DE59902666D1 (de) | Edelfosin zur behandlung von hirntumoren | |
| GR3037047T3 (en) | Combination therapy for advanced cancer comprising temozolomide and cisplatin | |
| HU9203148D0 (en) | Utilization of trinitro-benzoles and carminic acid for treatment of viral diseases and cancer | |
| MX9603833A (es) | Tratamiento mejorado del cancer con temozolomida. | |
| UA10928C2 (uk) | Спосіб профілактики гіперхолестериhемії | |
| WO2000033823A3 (en) | Methods of using temozolomide in the treatment of cancers | |
| RU96121507A (ru) | Способ лечения бесплодия у мужчин | |
| DE59506911D1 (de) | Verwendung von intravenös applizierbarem eisen zur therapie von tumorerkrankungen und/oder infektionskrankheiten | |
| GEP19991514B (en) | Method for Treatment with Interferon | |
| UA33890A (uk) | Спосіб лікування хвороби пейроні | |
| GB8924518D0 (en) | Treatment of eczema and other skin diseases | |
| MY109685A (en) | Method for treating hepatitis b carriers with minimal disease | |
| UA30125A (uk) | Спосіб лікування дітей з ревматоїдним артритом та дифузними хворобами сполучної тканини |